These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8913927)

  • 1. Transgenic and knockout analyses of the role of TNF in immune regulation and disease pathogenesis.
    Douni E; Akassoglou K; Alexopoulou L; Georgopoulos S; Haralambous S; Hill S; Kassiotis G; Kontoyiannis D; Pasparakis M; Plows D; Probert L; Kollias G
    J Inflamm; 1995-1996; 47(1-2):27-38. PubMed ID: 8913927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological functions of tumor necrosis factor and the consequences of its pathologic overexpression or blockade: mouse models.
    Kruglov AA; Kuchmiy A; Grivennikov SI; Tumanov AV; Kuprash DV; Nedospasov SA
    Cytokine Growth Factor Rev; 2008; 19(3-4):231-44. PubMed ID: 18502680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of systemic cytokines in the pathogenesis of polymicrobial sepsis and dehydroepiandrosterone treatment in a rodent model.
    Hildebrand F; Pape HC; Hoevel P; Krettek C; van Griensven M
    Shock; 2003 Oct; 20(4):338-46. PubMed ID: 14501948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelodysplasia and anemia of chronic disease in human tumor necrosis factor-alpha transgenic mice.
    Capocasale RJ; Makropoulos DA; Achuthanandam R; Stowell N; Quinn J; Rafferty PA; O'Brien J; Emmell E; Bugelski PJ
    Cytometry A; 2008 Feb; 73(2):148-59. PubMed ID: 18205195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-hormone and the immune system.
    Cantorna MT; Mahon BD
    J Rheumatol Suppl; 2005 Sep; 76():11-20. PubMed ID: 16142846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-alpha and CD95 ligation suppress erythropoiesis in Fanconi anemia C gene knockout mice.
    Otsuki T; Nagakura S; Wang J; Bloom M; Grompe M; Liu JM
    J Cell Physiol; 1999 Apr; 179(1):79-86. PubMed ID: 10082135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor (TNF)-induced cutaneous necrosis is mediated by TNF receptor 1.
    Amar S; Van Dyke TE; Eugster HP; Schultze N; Koebel P; Bluethmann H
    J Inflamm; 1995-1996; 47(4):180-9. PubMed ID: 9144075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of TNF-alpha producing T-cells in bone loss induced by estrogen deficiency.
    Roggia C; Tamone C; Cenci S; Pacifici R; Isaia GC
    Minerva Med; 2004 Apr; 95(2):125-32. PubMed ID: 15272247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases.
    Xanthoulea S; Pasparakis M; Kousteni S; Brakebusch C; Wallach D; Bauer J; Lassmann H; Kollias G
    J Exp Med; 2004 Aug; 200(3):367-76. PubMed ID: 15289505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor alpha (TNF-alpha) coordinately regulates the expression of specific matrix metalloproteinases (MMPS) and angiogenic factors during fracture healing.
    Lehmann W; Edgar CM; Wang K; Cho TJ; Barnes GL; Kakar S; Graves DT; Rueger JM; Gerstenfeld LC; Einhorn TA
    Bone; 2005 Feb; 36(2):300-10. PubMed ID: 15780956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble human p55 and p75 tumor necrosis factor receptors reverse spontaneous arthritis in transgenic mice expressing transmembrane tumor necrosis factor alpha.
    Edwards CK; Bendele AM; Reznikov LI; Fantuzzi G; Chlipala ES; Li L; Moldawer LL; Mountz JD; Li YY; Dinarello CA
    Arthritis Rheum; 2006 Sep; 54(9):2872-85. PubMed ID: 16947419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What does tumour necrosis factor excess do to the immune system long term?
    Clark J; Vagenas P; Panesar M; Cope AP
    Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv70-6. PubMed ID: 16239393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells.
    Ignatova ID; Kostadinova RM; Goldring CE; Nawrocki AR; Frey FJ; Frey BM
    Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E367-77. PubMed ID: 19088256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms for modulating TNF alpha in immune and inflammatory disease.
    Baugh JA; Bucala R
    Curr Opin Drug Discov Devel; 2001 Sep; 4(5):635-50. PubMed ID: 12825458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-receptor 2 is up-regulated on lamina propria T cells in Crohn's disease and promotes experimental colitis in vivo.
    Holtmann MH; Douni E; Schütz M; Zeller G; Mudter J; Lehr HA; Gerspach J; Scheurich P; Galle PR; Kollias G; Neurath MF
    Eur J Immunol; 2002 Nov; 32(11):3142-51. PubMed ID: 12555659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease.
    Apostolaki M; Manoloukos M; Roulis M; Wurbel MA; Müller W; Papadakis KA; Kontoyiannis DL; Malissen B; Kollias G
    Gastroenterology; 2008 Jun; 134(7):2025-35. PubMed ID: 18439426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functions of TNF and its receptors in renal disease: distinct roles in inflammatory tissue injury and immune regulation.
    Vielhauer V; Mayadas TN
    Semin Nephrol; 2007 May; 27(3):286-308. PubMed ID: 17533007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deleterious role of TNF-alpha in retinal ischemia-reperfusion injury.
    Berger S; Savitz SI; Nijhawan S; Singh M; David J; Rosenbaum PS; Rosenbaum DM
    Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3605-10. PubMed ID: 18660426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of tumor necrosis factor-alpha in down-regulation of hepatic cytochrome P450 and P-glycoprotein by endotoxin.
    Miyoshi M; Nadai M; Nitta A; Ueyama J; Shimizu A; Takagi K; Nabeshima T; Takagi K; Saito K; Hasegawa T
    Eur J Pharmacol; 2005 Jan; 507(1-3):229-37. PubMed ID: 15659313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-alpha-induced cardiomyopathy.
    Higuchi Y; McTiernan CF; Frye CB; McGowan BS; Chan TO; Feldman AM
    Circulation; 2004 Apr; 109(15):1892-7. PubMed ID: 15051641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.